RhumbLine Advisers’s Akso Health Group AHG Stock Holding History

RhumbLine Advisers’s Portfolio AHG Stock Details AHG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-4,540	Closed	-$5.54K	–	4120
2025 Q2	$5.54K	Sell	4,540 -490	-10%	-$657	﹤0.01%	3917
2025 Q1	$6.13K	Sell	5,030 -9,317	-65%	-$12.3K	﹤0.01%	3885
2024 Q4	$19.5K	Hold	14,347	–	–	﹤0.01%	3805
2024 Q3	$15.3K	Hold	14,347	–	–	﹤0.01%	3845
2024 Q2	$12.3K	Hold	14,347	–	–	﹤0.01%	3949
2024 Q1	$17.4K	Sell	14,347 -100	-0.7%	-$138	﹤0.01%	3783
2023 Q4	$10.1K	Hold	14,447	–	–	﹤0.01%	3859
2023 Q3	$15.5K	Sell	14,447 -5,493	-28%	-$3.15K	﹤0.01%	3816
2023 Q2	$6.98K	Buy	+19,940	New	+$6.55K	﹤0.01%	4013

Other funds holding AHG

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RhumbLine Advisers's AHG Position: Q3 2025 in Review

RhumbLine Advisers sold out of Akso Health Group (AHG) in Q3 2025, closing a stake of 4,540 shares — an estimated $5.54K sold.

RhumbLine Advisers first reported a position in AHG in Q2 2023 and held it in 9 quarters. The position peaked at $19.5K in Q4 2024. 4 funds tracked by Wall St. Rank hold AHG as of Q3 2025.

RhumbLine Advisers reported no remaining Akso Health Group position as of Q3 2025 after selling out during the quarter.
RhumbLine Advisers sold 4,540 Akso Health Group shares in Q3 2025, an estimated $5.54K.
RhumbLine Advisers first reported a position in Akso Health Group in Q2 2023 and held it in 9 quarters.
RhumbLine Advisers's Akso Health Group position peaked at $19.5K in Q4 2024.
4 funds tracked by Wall St. Rank held Akso Health Group as of Q3 2025.

Based on RhumbLine Advisers's 13F filing for Q3 2025, filed 6 Nov 2025.